HAL vs IMCR · P/E 9.3, $19.05B cap vs rev $310.2M
Halliburton Company (HAL) versus Immunocore Holdings Ltd (IMCR) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported IMCR revenue for 2024-12-31 was $310.2M. Net income was -$51.1M. Revenue was up 24.4% from 2023-12-31 to 2024-12-31. IMCR currently screens at market cap $1.45B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. IMCR currently screens at market cap $1.45B.
Not investment advice. Open the HAL and IMCR stock pages for the full models.
Not investment advice.